PANTOPRAZOLE MAGNESIUM DIN 02441853
Status: Cancelled Post Market
Holder: ALTIUS HEALTHCARE INC
Molecule: PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM)
Available to quote
Health Canada record
| Active ingredient(s) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) 40 MG |
|---|---|
| Dosage form | Tablet (Enteric-Coated) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A02BC02 PANTOPRAZOLE |
| Original market date | 25-Nov-2015 |
| Current status date | 24-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Altius Healthcare Inc. — licence 3-002438, currently licensed, last inspection rating C (2026-05-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02267233 | TECTA | TAKEDA CANADA INC | Tablet (Enteric-Coated) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) 40 MG | Marketed |
| 02440628 | TEVA-PANTOPRAZOLE MAGNESIUM | TEVA CANADA LIMITED | Tablet (Delayed-Release) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) 40 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19072 | 2017-03-16 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 17024 | 2015-06-23 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |